Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Proteins & Peptides
Filter     Order     Display # 
Date Item Title
21 Jul 2007 Yondelis (R) receives positive opinion in europe for the treatment of soft tissue sarcoma
21 Jul 2007 BioXell to regain rights to TREM platform following strategic decision by Merck & Co., Inc.
20 Jul 2007 Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union
20 Jul 2007 Tercica Completes Enrollment of Clinical Trial MS301 Evaluating Treatment with Increlex in Children with Primary IGFD
20 Jul 2007 Bone Medical Phase II Capsitonin(TM) (oral calcitonin)
18 Jul 2007 Ambrilia Completes Korean Licensing Partnership with Shin Poong for its Long-Acting Formulation of Octreotide
18 Jul 2007 CVBT Announces Positive Pre-Clinical Results for Protein-Based Drug Candidate to Treat Osteoporosis
17 Jul 2007 Affymax(R) Announces Phase 3 Development Plan for Hematide(TM)
17 Jul 2007 NPS Pharmaceuticals Announces Sale of Preotact(R) Royalty to Drug Royalty Corporation (DRC)
14 Jul 2007 Biolex Therapeutics Presents Preclinical Results for Clot Buster BLX-155 at the International Society on Thrombosis and Haemostasis Meeting
13 Jul 2007 Lab International announces positive results from its Growth Hormone Releasing Hormone (GHRH) Phase II trial
13 Jul 2007 SemBioSys achieves critical Apo AI milestone
13 Jul 2007 Bayer HealthCare Reports Positive Preclinical Study Results on Longer-Acting Recombinant Factor VIII Molecules
11 Jul 2007 Protox announces positive clinical data from prostate cancer study
11 Jul 2007 Sinobiomed Updates on Clincial Trial Progress for Recombinant Batroxobin (rBAT)
11 Jul 2007 CardioVascular BioTherapeutics Authorized to Initiate Phase II Trial of Angiogenesis Therapy for Severe Coronary Heart Disease
11 Jul 2007 Tercica Announces Agreement with Genentech for Worldwide Growth Hormone and IGF-1 Combination Product Development and Commercialization
10 Jul 2007 Roche and Alnylam form major alliance on RNAi therapeutics
10 Jul 2007 Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
06 Jul 2007 Phylogica expands pipeline to acute lung distress
06 Jul 2007 EMEA Approves Kamada’s Plans for Phase II / III Clinical Trials of the Aerosolized Form of AAT for the Treatment of Congenital Emphysema
04 Jul 2007 Mentor Announces Initial Patient Injections in Phase III Study for PurTox(R) Botulinum Toxin Type A
03 Jul 2007 Maxygen Initiates Phase IIa Clinical Trial of MAXY-G34 in Breast Cancer Patients
29 Jun 2007 Merck Serono's fertility treatment Pergoveris(TM) approved in European Union
29 Jun 2007 A 4-Week Therapy with Transition Therapeutics' E1-I.N.T.(TM) Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
29 Jun 2007 OMRIX Biopharmaceuticals Completes Patient Enrollment in Fibrin Patch Phase 1 Clinical Trial
29 Jun 2007 Protalex Reports Clinical Progress of PRTX-100 in Rheumatoid Arthritis and Idiopathic Thrombocytopenic Purpura
28 Jun 2007 Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
28 Jun 2007 Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target
28 Jun 2007 Alseres Pharmaceuticals Announces FDA Clearance to Increase Dose Level in Cethrin(R) Phase I/IIa Clinical Trial for Acute Spinal Cord Injury at U.S. Sites
27 Jun 2007 ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
26 Jun 2007 Generex Biotechnology to Initiate Phase III Clinical Trial of Generex Oral-lyn in 2007 Third Quarter
26 Jun 2007 PEGINTRON(TM) and REBETOL(R) Combination Therapy Approved in European Union for Treating Hepatitis C in Patients Coinfected With HIV
25 Jun 2007 Affymax(R) Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia
25 Jun 2007 Bentley Reports Positive Results with Nasulin(TM) Intranasal Insulin Spray at the American Diabetes Association Meeting
25 Jun 2007 BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
24 Jun 2007 SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
24 Jun 2007 BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
22 Jun 2007 Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
22 Jun 2007 Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
21 Jun 2007 Shire in-licenses JUVISTA(R) (human TGFβ3) from Renovo
21 Jun 2007 Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
21 Jun 2007 King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
20 Jun 2007 ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
20 Jun 2007 Merck Serono and Ambrx to collaborate on development of next generation growth hormone products
20 Jun 2007 Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
20 Jun 2007 ConjuChem Biotechnologies Reports PC-DAC(TM):Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
19 Jun 2007 Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
19 Jun 2007 Presentation of In Vivo HDL Kinetic Data at the European Atherosclerosis Society 76th Congress Demonstrates Activation of Reverse Cholesterol Transport by Pre-Beta HDL in Selectively Delipidated
16 Jun 2007 Novo Nordisk and Neose announce initiation of phase 1 clinical trial of long-acting factor VIIa
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>
Results 701 - 750 of 1495

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Janus Kinase (JAK) Inhibitors

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics